GGrantIndex
← Search

INVESTIGATION OF CLINICAL AND HORMONAL EFFECTS OF SOMATOSTATIN ANALOGUE

$28,104M01FY2000RRNIH

University Of Virginia Charlottesville, Charlottesville VA

Investigators

Linked publications & trials

Abstract

This study will determine whether somatostatin analogue Sandoz 201-995 is effective in suppressing hormone secretion by aggressive hypersecretory endocrine tumors. Hypersecretory endocrine tumors, particularly GH-producing tumors, respond to Somatostatin analog administration. There is no substantial effect on prolactin secreting tumors.

View original record on NIH RePORTER →